Consilient Health has launched an oral solution containing desmopressin 360 microgram per ml for the treatment of cranial diabetes insipidus and primary nocturnal enuresis. Previously, desmopressin oral solution or suspension was available only on a special order basis.
Click to search or browse MIMS
The most up-to-date drug information at your fingertips.
- Get the prescribing support you need.
- Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Read the latest issue online exclusively on MIMS Learning.
Access the full drug database and quick-reference tables on the go